Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: A hospital-based study

Tropical Medicine and International Health

Volumn 9, Issue 3, 2004, Pages 351-360

  Van Eijk, A M ^a,b   Ayisi, J G ^a,b   Ter Kuile, F O ^a,c   Otieno, J A ^d   Misore, A O ^d   Odondi, J O ^d   Rosen, D H ^a,c   Kager, P A ^b,f   Steketee, R W ^c,g   Nahlen, B L ^c,e  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d MINISTRY OF HEALTH   (Kenya)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Effectiveness; Kenya; Malaria; Pregnancy; Sulphadoxine pyrimethamine

Indexed keywords

FANSIDAR;

DISEASE CONTROL; HUMAN IMMUNODEFICIENCY VIRUS; MALARIA; PREGNANCY;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MONITORING; FEMALE; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MULTIVARIATE ANALYSIS; NEWBORN; PREGNANCY; PREVENTIVE MEDICINE; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIMALARIALS; BIRTH WEIGHT; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; KENYA; MALARIA; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PYRIMETHAMINE; SULFADOXINE; TIME FACTORS; TREATMENT OUTCOME;

AFRICA; EAST AFRICA; KENYA; KISUMU [NYANZA]; NYANZA; SUB-SAHARAN AFRICA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 12144286098     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2004.01196.x     Document Type: Article

References (14)

1. Bloland PB, Lackritz EM, Kazembe PN, Were JBO, Steketee RW & Campbell CC (1993) Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases 167, 932-937.
2. Brabin BJ (1983) An analysis of malaria in pregnancy in Africa. Bulletin of the World Health Organization 61, 1005-1016.
3. van Eijk AM, Ayisi JG, ter Kuile FO et al. (2002) Risk factors for malaria in pregnancy in an urban and periurban population in western Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 586-592.
4. Kaseje DC, Sempebwa EK & Spencer HC (1987) Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. I. Reasons for non-acceptance. Annals of Tropical Medicine and Parasitology 81 (Suppl. 1), 77-82.
5. Menendez C (1995) Malaria during pregnancy: a priority area of malaria research and control. Parasitology Today 11, 178-183.
6. Parise ME, Ayisi JG, Nahlen BL et al. (1998) Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. American Journal of Tropical Medicine and Hygiene 59, 813-822.
7. Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango C & Molyneux ME (2000) Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-1999. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 549-553.
8. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L & Wirima JJ (1994) The efficacy of antimalarial regimens containing sulphadoxine- pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. American Journal of Tropical Medicine and Hygiene 51, 515-521.
9. Schultz LJ, Steketee RW, Chitsulo L & Wirima JJ (1995) Antimalarials during pregnancy: a cost-effectiveness analysis. Bulletin of the World Health Organization 73, 207-214.
10. Shulman CE, Dorman EK, Cutts F et al. (1999) Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy, a randomized placebo-controlled trial. Lancet 353, 632-636.
11. Steketee RW, Wirima JJ, Hightower AW, Slutsker L, Heymann DL & Breman JG (1996) The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity and intrauterine growth retardation in rural Malawi. American Journal of Tropical Medicine and Hygiene 55 (Suppl.), 33-41.
12. Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB & Broadhead RL (1998) An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Annals of Tropical Medicine and Parasitology 92, 141-150.
13. Verhoeff FH, Brabin BJ, Hart CA, Chimsuku L, Kazembe P & Broadhead R (1999) Increased prevalence of malaria in HIV infected pregnant women and its implications for malaria control. Tropical Medicine and International Health 4, 5-12.
14. WHO (2000) Expert Committee on Malaria. Twentieth Report. Document WHO 12/19/00 11:38:42. WHO, Geneva.